No Data
No Data
Sanbo Neurology (301293.SZ): for the first time repurchased 0.1642 million shares involving 5.6972 million yuan.
On July 19th, Gelonghui reported that Sanbo Brain (301293.SZ) announced that on July 18, 2024, they repurchased 164,160 shares of the company through a repurchase dedicated security account, accounting for 0.08/% of the total share capital of the company, with the highest transaction price of 34.80 yuan/share, the lowest transaction price of 34.46 yuan/share, and a total transaction amount of 5.6972 million yuan (excluding transaction fees) in a centralized bidding manner.
Sanbo Neurology (301293.SZ) is a medical service group specializing in neurological care.
Sanbo Brain Science (301293.SZ) stated on the investor interaction platform on July 18th that it is a medical service group with a focus on neurology. It currently operates seven hospitals, including five specialized in neurology and two comprehensive hospitals. The main diagnosis and treatment projects of the hospital include neurosurgery, neurological intervention, neurology, chemotherapy/radiotherapy for neurotumors, neurocritical care, obstetrics and gynecology, pediatrics, etc.
Sanbo Neurology (301293.SZ) plans to acquire 70% equity of Sichuan Guangze Medical Investment Management.
On July 11th, Guolonghui reported that Sanbo Brain Hospital Management Group Co., Ltd. intends to further integrate resources, businesses, and supply chains in the southwestern regional market. On July 10th, 2024, the company signed an Equity Acquisition Intention Letter with Sichuan Dahang Guangze Medical Investment Management Co., Ltd. (referred to as the 'target company') and its shareholders Zhang Pingzhong, Cao Deli, Xiao Jing, and Zhou Qin to acquire 70% of the equity of the target company in cash.
Sanbo Neurology (301293.SZ): No involvement in the assisted reproduction business at this time.
On July 8th, Gelonhui reported that Sanbo Neurology (301293.SZ) stated on the investor interactive platform that its subsidiary, Luoyang Sanbo, mainly focuses on obstetrics, gynecology, and pediatrics, and does not currently involve assisted reproduction business.
AH trends diverge, Hang Seng Index up 0.6%, CNOOC up 4%, national bond futures slightly rebound.
Rare earth permanent magnets concept stocks pull back, photovoltaic and lithography themes also weaken. Hong Kong's real estate, banks, and oil & gas stocks are strong, CNOOC up 4%, Agricultural Bank of China and China Merchants Bank rise more than 2%. After experiencing a sharp drop yesterday, national bond futures rebounded in early trading, with 10-year and 30-year national bond futures contracts rising nearly 0.1% in early trading.
Sanbo Neurology (301293.SZ): Share repurchase has not yet been implemented.
On July 1st, Gelunhui reported that Sanbot Brain (301293.SZ) has opened a repurchase special securities account as of June 30, 2024, but has not yet implemented stock repurchases.
No Data